G. Lc-ms-(-n-) and L. Ms, Acute kidney injury associated with synthetic cannabinoid use--multiple states, 6697?719. v Centers for Disease Control and Prevention (CDC), pp.93-101, 2012.

F. Chavant, A. Boucher, L. Boisselier, R. Deheul, S. Debruyne et al., New Synthetic Drugs in Addictovigilance, Th??rapie, vol.70, issue.2, pp.179-89, 2015.
DOI : 10.2515/therapie/2015001

P. Dargan, S. Albert, and D. Wood, Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change, QJM, vol.81, issue.954, 2010.
DOI : 10.1136/pgmj.2004.024794

. Daveluy, Poisoning by Synthetic Cathinones: Consumption Behaviour and Clinical Description from 11 Cases Recorded by the Addictovigilance Centre of Bordeaux Toxicologie Analytique et Clinique, New Psychoactive Substances Analytical and Clinical Issues in 2017, pp.34-40, 2017.

B. Dean, S. Stellpflug, and A. Burnett, 2C or Not 2C: Phenethylamine Designer Drug Review, Journal of Medical Toxicology, vol.12, issue.2, pp.172-178
DOI : 10.3109/10903127.2011.627108

URL : http://europepmc.org/articles/pmc3657019?pdf=render

N. Frydman and H. Martineau, La drogue : où en sommes-nous ? Paris : la Documentation française, 1998.

M. Ghysel-laporte, P. Sibille, and N. Milan, Amphétamines et dérivés Traité de toxicologie médico-judiciaire, pp.455-505, 2012.

J. Goullé, Immunochimie??: quelle place en 2008???, Annales de Toxicologie Analytique, vol.21, issue.1, pp.49-53, 2008.
DOI : 10.1051/ata/2009024

. Griggs, A fatal poisoning with LSD Biosynthesis of amphetamine analogs in plants, Forensic Sci Trends in Plant Science, vol.28, issue.7, pp.17-404, 2012.

M. Herkenham, A. Lynn, M. Johnson, L. Melvin, B. De-costa et al., Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study, The Journal of Neuroscience, vol.11, issue.2, pp.563-83, 1991.
DOI : 10.1523/JNEUROSCI.11-02-00563.1991

. Hill, Severe clinical toxicity associated with analytically confirmed recreational use of 25I???NBOMe: case series, Clinical Toxicology, vol.50, issue.6, pp.487-92, 2013.
DOI : 10.1016/j.pharmthera.2003.11.002

A. Howlett and J. Shim, Cannabinoid Receptors and Signal Transduction Disponible sur: http://www.ncbi.nlm.nih.gov/books/NBK6154/ v Huffman JW et al. Synthesis and pharmacology of 1-deoxy analogs of CP47, Bioorg Med Chem, vol.16, pp.497-55940, 2000.

B. Hugues and T. Blidaru, LegalResponses to New Psychoactive Substances in Europe, Lisbonne : EMCDDA LegalDatabase on Drugs, 2009.

D. James, R. Adams, R. Spears, G. Cooper, D. Lupton et al., Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service, Emergency Medicine Journal, vol.28, issue.8, 2010.
DOI : 10.1136/emj.2010.096636

R. Johnson, S. Botch-jones, T. Flowers, and C. Lewis, An evaluationof 25B-, 25C-, 25D-, 25H-, 25I- and 25T2-NBOMe via LC-MS-MS: method validation and analyte stability, J Anal, vol.38, issue.8, pp.479-84, 2014.
DOI : 10.1093/jat/bku085

URL : https://academic.oup.com/jat/article-pdf/38/8/479/18772556/bku085.pdf

L. Karila, B. Megarbane, O. Cottencin, and M. Lejoyeux, Synthetic Cathinones: A New Public Health Problem, Current Neuropharmacology, vol.13, issue.1, pp.12-20, 2015.
DOI : 10.2174/1570159X13666141210224137

URL : http://europepmc.org/articles/pmc4462036?pdf=render

H. Persson, G. Sjöberg, J. Haines, P. De-garbino, and J. , Poisoning Severity Score. Grading of Acute Poisoning, Journal of Toxicology: Clinical Toxicology, vol.106, issue.3, pp.205-218, 1998.
DOI : 10.1136/bmj.2.6028.153

J. L. Poklis, Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death, Forensic Science International, vol.234, issue.81, pp.14-20, 2014.
DOI : 10.1016/j.forsciint.2013.10.015

M. Rajasekaran, L. Brents, L. Franks, J. Moran, and P. Prather, Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors, Toxicology and Applied Pharmacology, vol.269, issue.2, pp.100-108, 2013.
DOI : 10.1016/j.taap.2013.03.012

. Rogers and R. Carl, The processes of therapy., Journal of Consulting Psychology, vol.4, issue.5, pp.161-164, 1940.
DOI : 10.1037/h0062536

S. R. Rose, J. L. Poklis, and A. Poklis, A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug, Clinical Toxicology, vol.90, issue.3, pp.174-177, 2013.
DOI : 10.1111/j.1556-4029.2009.01199.x

. Roussel, Premiers cannabinoïdes de synthèse au centre antipoison et de toxicovigilance d'Angers : à propos de quatre cas, Toxicologie Analytique et Clinique The Development of New Psychoactive Substances in France, Toxicologie Analytique et Clinique, New Psychoactive Substances Analytical and Clinical Issues, vol.27, issue.29 1, pp.63-90, 2015.

. Saleh, Limb-Threatening Ischemia in a Young Man with Cathinone "Bath Salt Intoxication: A Case Report Ann Vasc Surg, Saussereau E. Les cathinones : qu'en sait-on aujourd'hui ? Toxicologie Analytique et Clinique, pp.294-295, 2014.

K. Seely, J. Lapoint, J. Moran, and L. Fattore, Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.39, issue.2, pp.234-277, 2012.
DOI : 10.1016/j.pnpbp.2012.04.017

J. P. Smith, O. B. Sutcliffe, and C. Banks, An overview of recent developments in the analytical detection of new psychoactive substances (NPSs), The Analyst, vol.208, issue.Suppl 1, 2015.
DOI : 10.1016/j.forsciint.2010.10.025